BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15923804)

  • 1. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
    Dusenbery KE; Potish RA; Argenta PA; Judson PL
    Am J Clin Oncol; 2005 Jun; 28(3):295-300. PubMed ID: 15923804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.
    Dusenbery KE; Potish RA; Judson P
    Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy.
    Murphy KT; Rotmensch J; Yamada SD; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1272-6. PubMed ID: 12654437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
    Kushner DM; Webster KD; Belinson JL; Rybicki LA; Kennedy AW; Markman M
    Gynecol Oncol; 2000 Aug; 78(2):221-7. PubMed ID: 10926807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant management of operated uterine sarcomas: A single institution experience.
    Cordoba A; Prades J; Basson L; Robin YM; Taïeb S; Narducci F; Hudry D; Bresson L; Chevalier A; Le Tinier F; Mirabel X; Lartigau É; Penel N; Leblanc É
    Cancer Radiother; 2019 Sep; 23(5):401-407. PubMed ID: 31351809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy in early stage uterine sarcomas: an open question.
    Gadducci A; Romanini A
    Eur J Gynaecol Oncol; 2001; 22(5):352-7. PubMed ID: 11766739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group.
    Pautier P; Floquet A; Gladieff L; Bompas E; Ray-Coquard I; Piperno-Neumann S; Selle F; Guillemet C; Weber B; Largillier R; Bertucci F; Opinel P; Duffaud F; Reynaud-Bougnoux A; Delcambre C; Isambert N; Kerbrat P; Netter-Pinon G; Pinto N; Duvillard P; Haie-Meder C; Lhommé C; Rey A
    Ann Oncol; 2013 Apr; 24(4):1099-104. PubMed ID: 23139262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy and/or chemotherapy as adjuvant treatment of uterine sarcomas.
    Sorbe B
    Gynecol Oncol; 1985 Mar; 20(3):281-9. PubMed ID: 3838290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant mixed Mullerian tumors.
    Ruiz Tovar J; Reguero Callejas ME; Arano Bermejo JI; Capote Armas LF; González-Palacios Martínez F; Cabañas Navarro L
    Clin Transl Oncol; 2006 Feb; 8(2):129-32. PubMed ID: 16632428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative pelvic irradiation in early stage uterine mixed mullerian tumors.
    Molpus KL; Redlin-Frazier S; Reed G; Burnett LS; Jones HW
    Eur J Gynaecol Oncol; 1998; 19(6):541-6. PubMed ID: 10215437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of postoperative radiotherapy in the treatment of uterine sarcomas: a retrospective analysis of 46 patients.
    Yalman D; Ozsaran Z; Baltalarli B; Demir O; Ozdemir N; Aras A
    Eur J Gynaecol Oncol; 2008; 29(1):46-51. PubMed ID: 18386463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed müllerian tumors of the uterus.
    Wong L; See HT; Khoo-Tan HS; Low JS; Ng WT; Low JJ
    Int J Gynecol Cancer; 2006; 16(3):1364-9. PubMed ID: 16803531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the Grup Oncologic Català-Occità.
    Ferrer F; Sabater S; Farrús B; Guedea F; Rovirosa A; Anglada L; Delannes M; Marín S; DuBois JB; Daly-Schveitzer N
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):47-52. PubMed ID: 10219793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia).
    Ferrandina G; Aristei C; Biondetti PR; Cananzi FCM; Casali P; Ciccarone F; Colombo N; Comandone A; Corvo' R; De Iaco P; Dei Tos AP; Donato V; Fiore M; Franchi ; Gadducci A; Gronchi A; Guerriero S; Infante A; Odicino F; Pirronti T; Quagliuolo V; Sanfilippo R; Testa AC; Zannoni GF; Scambia G; Lorusso D
    Eur J Cancer; 2020 Nov; 139():149-168. PubMed ID: 32992154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
    Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
    Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of radiotherapy treatment of uterine sarcoma.
    Sampath S; Gaffney DK
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):761-72. PubMed ID: 21783424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
    Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.